Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

TCET Final Notice Leaves Much To Be Desired, Eyes Turn To Congress

08 Aug 2024

• By Hannah Daniel

• Source: Shutterstock

Related Content

Expanding Device Eligibility And Other Suggestions For CMS’s TCET Pathway

31 Aug 2023

CMS Proposes New TCET Pathway, But How Much Difference Will It Make?

27 Jun 2023

It’s Been Over 1100 Days Since MCIT, Still No TCET In Sight

15 Apr 2024

Amendments To Breakthrough Device Coverage Act Push Bill Out Of House Ways And Means Committee

01 Jul 2024

Additional Topics

United States Policy Reimbursement Medicaid Medical Device

More from Policy & Regulation

More from Medtech Insight

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window

Copyright © 2025 Pharma Intelligence UK Limited (Citeline), a Norstella company Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered.